Brian Farrell
Neurological Surgery · Paducah, KYNPI 1073766150
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,164 of the $4,869 with a category attached, or 65.0%. Medtronic accounts for 65.2% of it on its own, with 28 other manufacturers making up the rest. Reporting peaked in 2019 at $1,453 and has fallen 95.3% since, to $69 in 2025.
Across 94 payments — averaging $51.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Si-bone, Inc.$690
- Cerapedics Inc.$157
- Avanir Pharmaceuticals, Inc.$115
- AbbVie$87
- Zimmer Biomet$62
- plus $583 from 23 others
What the payments were for
- Travel & lodging$1,70535%
- Food & beverage$3,16465%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 33 | $3,175 |
| Si-bone, Inc. | 12 | $690 |
| Cerapedics Inc. | 2 | $157 |
| Avanir Pharmaceuticals, Inc. | 7 | $115 |
| AbbVie | 4 | $87 |
| Zimmer Biomet | 1 | $62 |
| Teva Pharmaceuticals USA, Inc. | 4 | $61 |
| Jazz Pharmaceuticals Inc. | 3 | $53 |
| Boston Scientific | 2 | $51 |
| SK Life Science, Inc. | 2 | $43 |
| UCB, Inc. | 3 | $42 |
| Grifols USA, LLC | 2 | $38 |
| Livanova USA, Inc. | 2 | $31 |
| Lilly USA, LLC | 2 | $24 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| Johnson & Johnson | 1 | $22 |
| Biogen | 1 | $19 |
| Banner Life Sciences, LLC | 1 | $18 |
| Inspire Medical Systems, Inc. | 1 | $18 |
| Mallinckrodt Hospital Products Inc. | 1 | $17 |
| Supernus Pharmaceuticals, Inc. | 1 | $16 |
| Akcea Therapeutics, Inc. | 1 | $16 |
| Neurelis, Inc. | 1 | $14 |
| Neurocrine Biosciences, Inc. | 1 | $14 |
| Amgen | 1 | $13 |
| Abbott | 1 | $13 |
| Amneal Pharmaceuticals LLC | 1 | $13 |
| AstraZeneca | 1 | $13 |
| Tanabe Pharma America, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,869 in reported general payments places this provider in the 60th percentile of 99 neurological surgery providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 48 | $525 |
| Tizanidine Hcl | 37 | $325 |
| Pregabalin | 31 | $294 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 18 | $285 |
| Methylprednisolone | 11 | $59 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Paducah
- Thomas GruberPaducah$45K
- Jonathan CouchPaducah$4K
- Tom YaoLouisville$405K
- Joseph NeimatLouisville$196K
- Maria KoutourousiouLouisville$189K
- Shervin DashtiLouisville$146K
- Shawn AdamsLouisville$73K
- Matthew TuttLexington$64K
- Craig VanhorneLexington$64K
- Nathaniel ToopLouisville$56K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.